Indrayani Biotech Ltd Intrinsic Value
INDRANIB · FMCG · Current price ₹8.2
Is Indrayani Biotech Ltd undervalued?
DocStoX estimates the fair value of Indrayani Biotech Ltd at ₹18 per share, versus the current market price of ₹8. That puts the stock about +123.7% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹12), Relative P/E (₹29), Graham floor (₹22). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹12 (bear) to ₹18 (base) to ₹29 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹8 versus an intrinsic value of ₹18, Indrayani Biotech Ltd currently offers +123.7% of margin.
More on Indrayani Biotech Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.